OVARIAN EPITHELIAL CANCER RECURRENT

This adverse event was reported 54 times

These drugs are most commonly taken by patients reporting OVARIAN EPITHELIAL CANCER RECURRENT:

# Drug Count
0 CARBOPLATIN 26
1 PACLITAXEL 23
2 PACLITAXEL (AIBUMIN-BOUND) 23
3 NIRAPARIB 11
4 DOXORUBICIN 10
5 BEVACIZUMAB 9
6 DOXORUBICIN HYDROCHLORIDE 8
7 OLAPARIB 4
8 IMATINIB MESYLATE 3
9 CISPLATIN 2
See all common drugs associated with OVARIAN EPITHELIAL CANCER RECURRENT

OVARIAN EPITHELIAL CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PAFOLACIANINE INJECTION 1 0.0159
1 TREOSULFAN 2 0.0007
2 MIRVETUXIMAB SORAVTANSINE 1 0.0006
3 NIRAPARIB 11 0.0005
4 DECITABINE 2 0.0005
5 TOPOTECAN HYDROCHLORIDE 1 0.0004
6 DOXORUBICIN HYDROCHLORIDE 8 0.0002
7 PACLITAXEL 23 0.0002
8 CARBOPLATIN 26 0.0002
9 OLAPARIB 4 0.0002
See all drugs enriched for association with OVARIAN EPITHELIAL CANCER RECURRENT